Clinical Report: Impact of the Personalized Glaucoma Coaching Program
Overview
The Support, Educate, Empower (SEE) program significantly improved medication adherence in glaucoma patients compared to enhanced usual care. The intervention led to a 19.7 percentage point increase in adherence rates and reduced glaucoma-related distress.
Background
Glaucoma is a leading cause of irreversible vision loss, particularly among Black individuals, with a projected increase in prevalence as the population ages. Nonadherence to prescribed eye drop medications is a major factor contributing to vision loss in glaucoma patients. Effective interventions are needed to enhance medication adherence and improve patient outcomes.
Data Highlights
Outcome
SEE Program
Enhanced Usual Care
Medication Adherence
77.6%
58.0%
Achieved ≥80% Adherence
54.9%
23.7%
Key Findings
The SEE program improved electronically monitored medication adherence by 19.7 percentage points compared to enhanced usual care.
54.9% of participants in the SEE group achieved ≥80% adherence, compared to 23.7% in the control group.
Glaucoma-related distress decreased more significantly in the SEE intervention group.
Intraocular pressure changes were minimal, aligning with the focus on adherence rather than immediate clinical outcomes.
The program utilized motivational interviewing and personalized multimedia education to support patient engagement.
Clinical Implications
Healthcare providers should consider implementing structured coaching programs like SEE to enhance medication adherence among glaucoma patients. Addressing barriers to adherence through personalized support can lead to improved patient outcomes and reduced vision loss.
Conclusion
The SEE program demonstrates that personalized coaching can effectively improve medication adherence in glaucoma patients, highlighting the importance of tailored interventions in chronic disease management.
